Temocillin vs Meropenem for the Treatment of Third Generation Cephalosporin-Resistant Enterobacterial Bacteremia: A Randomized and Pragmatic Trial

INDEPENDENT CLINICAL TRIAL

Home · MP14-Infectious Diseases Group-ibs.Granada. XNUMXst Century

Clinical trial information

Promoter: PUBLIC ANDALUSIAN FOUNDATION FOR THE MANAGEMENT OF HEALTH RESEARCH IN SEVILLE
Phase: III
Execution start: 20/10/2020
End of execution: 30/10/2020
IP: